Clinical trials: Herpetic Keratitis

Persistent Corneal Epithelial Defects

Efficacy and Safety Study of Nexagon for Persistent Corneal Epithelial Defects

• Terminated
• Age: 18 years and older
• Phase 2
• Results posted

The purpose of this study is to evaluate the efficacy and safety of Nexagon® in subjects with persistent corneal epithelial defects (PED) resulting from corneal epithelial debridement during diabetic vitrectomy surgery, HSV…

Trial name

NTX-PED-001 (NCT01165450)

Testing

Nexagon, Vehicle only

Volunteers

2 people

Sponsor

University of California, San Francisco